JP2020509997A5 - - Google Patents

Download PDF

Info

Publication number
JP2020509997A5
JP2020509997A5 JP2019539888A JP2019539888A JP2020509997A5 JP 2020509997 A5 JP2020509997 A5 JP 2020509997A5 JP 2019539888 A JP2019539888 A JP 2019539888A JP 2019539888 A JP2019539888 A JP 2019539888A JP 2020509997 A5 JP2020509997 A5 JP 2020509997A5
Authority
JP
Japan
Prior art keywords
oxybiotin
alkyl
otbs
independently
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019539888A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020509997A (ja
JP7310064B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2018/073526 external-priority patent/WO2018133854A1/en
Publication of JP2020509997A publication Critical patent/JP2020509997A/ja
Publication of JP2020509997A5 publication Critical patent/JP2020509997A5/ja
Application granted granted Critical
Publication of JP7310064B2 publication Critical patent/JP7310064B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019539888A 2017-01-20 2018-01-20 アデノシン類似体及びその概日リズム時計調整における使用 Active JP7310064B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2017/071903 2017-01-20
CN2017071903 2017-01-20
PCT/CN2018/073526 WO2018133854A1 (en) 2017-01-20 2018-01-20 Adenosine analog and its use in regulating the circadian clock

Publications (3)

Publication Number Publication Date
JP2020509997A JP2020509997A (ja) 2020-04-02
JP2020509997A5 true JP2020509997A5 (https=) 2022-05-31
JP7310064B2 JP7310064B2 (ja) 2023-07-19

Family

ID=62907767

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019539888A Active JP7310064B2 (ja) 2017-01-20 2018-01-20 アデノシン類似体及びその概日リズム時計調整における使用

Country Status (5)

Country Link
US (1) US20210338706A1 (https=)
EP (1) EP3571211A4 (https=)
JP (1) JP7310064B2 (https=)
CN (1) CN110291095B (https=)
WO (2) WO2018133835A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202109090SA (en) 2019-02-22 2021-09-29 Promaxo Inc Pseudo-birdcage coil with variable tuning and applications thereof
CN110183504B (zh) * 2019-06-13 2023-07-07 湖南大学 一种具有肿瘤靶向性的吉西他滨前体药物及其制备方法和用途
CN113563401A (zh) * 2021-07-14 2021-10-29 河南牧业经济学院 一种新型虫草素烷酰胺衍生物及其制备方法和应用
KR20240058859A (ko) 2021-08-12 2024-05-03 쿨레온 엘엘씨 환각성 및 비환각성 세로토닌 수용체 작용제 및 이의 제조 및 사용 방법
CN117660572A (zh) * 2023-12-12 2024-03-08 中科药创(青岛)发酵工程有限公司 一种多功效高虫草素含量的蛹虫草固体发酵产物及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6164M (https=) * 1966-10-13 1968-07-08
US4386093A (en) * 1981-09-16 1983-05-31 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services (±)3-Deazaaristeromycin and uses
SU1119336A1 (ru) * 1983-01-27 1986-12-30 Институт биоорганической химии АН БССР Способ получени 9- @ - @ -ксилофуранозиладенина
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
US6638963B1 (en) * 1990-12-04 2003-10-28 Oregon Health And Science University Methods for treating circadian rhythm disorders
US5366960A (en) * 1993-08-26 1994-11-22 Warner-Lambert Company Method of treating cerebral and cardiovascular disorders employing [R]3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidaz 0-[4,5-d][1,3]diazepin-8-ol
EP0863148A1 (en) * 1997-03-03 1998-09-09 K.U. Leuven Research & Development Compounds derived from adenosine, use of such compound as a medicament, method for synthesizing such a compound and intermediates thereof
DE50207103D1 (en) * 2001-03-14 2006-07-20 Gruenenthal Gmbh Substituierte pyrazolo- und thiazolopyrimidine als analgetika
CN101259129A (zh) * 2002-11-06 2008-09-10 惠氏公司 急性白血病和骨髓异常增生综合征的组合治疗
ATE445396T1 (de) * 2004-08-19 2009-10-15 Aventis Pharma Inc 3-arylthioindol-2-carbonsäureamidderivate und ihre analoge als hemmer von caseinkinase i
WO2007111954A2 (en) * 2006-03-23 2007-10-04 Inotek Phamaceuticals Corporation Purine compounds and methods of use thereof
GB0610059D0 (en) * 2006-05-19 2006-06-28 Medical Res Council Uses and methods
ES2425179T3 (es) * 2006-10-25 2013-10-11 The Rockefeller University Métodos para el tratamiento de trastornos relacionados con beta-amiloide y composiciones para los mismos
KR101961601B1 (ko) * 2009-11-16 2019-03-25 유니버시티 오브 조지아 리서치 파운데이션, 인코포레이티드 바이러스 감염 치료를 위한 ２＇―플루오로―６＇―메틸렌 카보사이클릭 뉴클레오사이드 및 방법
PE20160203A1 (es) * 2013-08-19 2016-04-20 Hoffmann La Roche Antagonistas de via para tratar trastornos del sueno por cambio de fase
WO2016106704A1 (en) * 2014-12-31 2016-07-07 Nestec S.A. A process for preparing a cordyceps extract
PL3280414T3 (pl) * 2016-04-15 2024-06-24 Oxford University Innovation Limited Modulatory receptora adenozyny w leczeniu schorzeń rytmu okołodobowego

Similar Documents

Publication Publication Date Title
JP2020509997A5 (https=)
CN114751903B (zh) 一类含氮稠杂环类shp2抑制剂化合物、制备方法和用途
JP7130123B2 (ja) Ｍｓｔ１キナーゼ阻害剤及びその使用
JP7299837B2 (ja) 化合物、組成物、および使用方法
JP2011515337A5 (https=)
CN114206848A (zh) 作为整合应激通路的调节剂的被取代的环烷基化合物
CN112204009A (zh) 整合应激通路的调节剂
CN114401952A (zh) 作为整合应激通路的调节剂的被取代的环烷基化合物
JP2021527126A5 (https=)
JP2021501768A (ja) Ｂ型肝炎ウイルス（ｈｂｖ）に対し活性を有する新規の高活性なピラゾロ−ピペリジン置換インドール−２−カルボキサミド
CN112218869A (zh) 整合应激通路的调节剂
JP2022511819A (ja) ヘテロアリールジヒドロピリミジン誘導体及びｂ型肝炎感染症を治療する方法
IL233739A (en) Imidazopyrolidinone Compounds
JP2007531760A5 (https=)
JP2012519691A5 (https=)
RU2010112408A (ru) Фосфадиазиновые ингибиторы iv полимеразы hcv
ES2892956T3 (es) Moduladores alostéricos positivos del receptor muscarínico de acetilcolina M4
EP4223759B1 (en) Pyrazolopyridazinone compound, and pharmaceutical composition and use thereof
JP2020524148A (ja) 置換５−シアノインドール化合物及びその使用
ES2907858T3 (es) Compuestos y métodos para el tratamiento de infecciones bacterianas
BR112021005054A2 (pt) terapia de combinação para tratamento contra câncer no sangue
EP3534901A1 (en) Positive allosteric modulators of the muscarinic acetylcholine receptor m4
JP2020516616A5 (https=)
JP2022544538A5 (https=)
CN113166059A (zh) 小分子menin抑制剂